Why IMU is not a multi-bagger and now will never be, page-36

First 36 Last

Share
Profile

Follow
borano

2,735 Posts.

294

11/04/24

11:18

Post #: 73292940
Share

Originally posted by freebooter43: ↑

Good time to read a few quotes from Warren Buffett on fear.

I happen to like; ""What investors then need instead is an ability to both disregard mob fears or enthusiasms and to focus on a few simple fundamentals"

Some points to consider:
1. Company fundamentals haven't changed.
2. Trials are still in progress.
3. Very sick patients are still seeing some control over their disease. Some have reduced tumour burden, or are cured.

Sure, a data cut that was never promised for the AARC poster presentation but hoped for by shareholders was not delivered. Yet it was explained earlier for those who listened that there are costs and reasons as to why it takes time. Blind Freddy would know that trials have timelines, patients to recruit, and minimum data sets to reach to ensure results are statistically significant.

It might very well be that the latest results are fantastic, yet what's the point of presenting those if they are not at a point in the timeline where they prove statistical significance at higher doses. You would be laughed out of the scientific community.

And even if they are not as good as we all hope, there is enough to show at the lower doses that CF33 controls disease, that CF33 can lock onto a solid tumour. That all makes oncarlytics even more so valuable (if it works).

So ....

Question: Was what was presented to those attending the presentation at AACR 2024 new news to those that attended AACR in 2023 and those not familiar with CF33 and the Imugene story.

Answer: Resoundingly, yes!

Question: Was the data presented compelling? Might it invite further interest in Imugene and the current trials.

Answer: Resoundingly, yes!

Question: Is Big Pharma so deviod of ways to engage with Imugene, that they are now lost to Imugene forever because of a poster presentation.

Answer: Some rabid mob would say yes! But I will leave you to decide.

Question: Why so much concerted effort past couple of days by a mob to instil fear?

Answer: Ask Warren Buffett!

Expand

@freebooter43

Your questions and answers are all your hypotheticals. What a load of BS to even mention Warren Buffet

Warren Buffet does not invest in Biotech

In fact he has no biotech companies in Berkshire Hathaway portfolio.

ZILCH!

You seem to definitely be just another dreamer.

By thed way, you could see after the close of market yesterday, it was going to be a terrible day for IMU. The amount of buyers that dropped off was scary.
Now there is no buying depth. Next stop possibly under 9 cents. Finally! LOL

IMU Price at posting: 9.6¢ Sentiment: Sell Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

NEU

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

First 36 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.1¢		Change 0.000(0.00%)		Mkt cap ! $82.13M

Open	High	Low	Value	Volume
1.1¢	1.2¢	1.1¢	$286.1K	25.98M

Buyers (Bids)

No.	Vol.	Price($)
22	5307400	1.1¢

Sellers (Offers)

Price($)	Vol.	No.
1.2¢	12024866	55

View Market Depth

No.	Vol.	Price($)
22	5320474	0.011
110	28289836	0.010
38	16314446	0.009
12	3890622	0.008
7	3365713	0.007

Price($)	Vol.	No.
0.012	9124366	55
0.013	8240554	28
0.014	8302051	33
0.015	8094214	28
0.016	6655871	28

Last trade - 14.33pm 26/06/2025 (20 minute delay)

IMU (ASX) Chart

Why IMU is not a multi-bagger and now will never be, page-36

Australia’s gas crisis is here – and dying coal plants aren’t helping

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Why IMU is not a multi-bagger and now will never be, page-36

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News